No Data
No Data
Express News | Incyte Corp - Phase 3 Pod1Um-304 Trial Meets Primary and Secondary Endpoints
Express News | Incyte Announces Positive Results From Phase 3 Trial Evaluating Retifanlimab (Zynyz®) in Combination With Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer
Weekly Buzz: Now THOSE are records!!
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Index Records are BACK for Friday Market While Unemployment Climbs | Live Stock
Unlock the Full List